Publication

New Treatment Strategies Making an Impact in Multiple Myeloma.

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Charise Gleason, Emory UniversityJonathan Kaufman, Emory University
Language
  • English
Date
  • 2017-04
Publisher
  • Harborside Press
Publication Version
Copyright Statement
  • © 2017, Harborside Press
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 8
Issue
  • 3
Start Page
  • 285
End Page
  • 290
Abstract
  • Even though multiple myeloma remains incurable, mean overall survival has improved dramatically as newer game-changing therapies enter the scene. At the same time, treatment decisions and the management of toxicities related to newer drug regimens are becoming more complex.
Author Notes
  • Ms. Gleason has consulted for Karyopharm and Takeda. Dr. Kaufman has consulted for Bristol-Myers Squibb, Celgene, Incyte, and Pharmacyclics.
Keywords
Research Categories
  • Health Sciences, Toxicology
  • Health Sciences, Oncology
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items